Clinical Trial Update: Topotecan by Intracerebral Clysis for Recurrent Primary Malignant Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intracerebral infusion of topotecan for recurrent primary malignant brain neoplasms has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Brain Neoplasms

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Jeffrey N. Bruce | Conditions: Brain Neoplasms, Primary Malignant | Phase 1 | Status: COMPLETED | Results posted: 2025-06-27